H. Wolf
Impact in
-
- Chronic Lymphocytic Leukemia Research
-
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Papers in
- Oncology 7
- Neutropenia and Cancer Infections 6
- COVID-19 and healthcare impacts 2
-
- Acute Myeloid Leukemia Research 1
- Chronic Myeloid Leukemia Treatments 1
- Hematopoietic Stem Cell Transplantation 1
- Co-authors
- Dirk Arnold (2 shared papers)Karin Jordan (2 shared papers)Hans‐Joachim Schmoll (2 shared papers)Wieland Voigt (2 shared papers)Axel Hinke (1 shared paper)Axel F. Grothey (1 shared paper)Marcus Hentrich (3 shared papers)Marie von Lilienfeld‐Toal (3 shared papers)
- Journals
- European Journal of Cancer (2 papers)Annals of Oncology (2 papers)Blood (1 paper)Supportive Care in Cancer (1 paper)Acta Neurologica Scandinavica (1 paper)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
H. Wolf
15 papers receiving 318 citations
Peers
Comparison fields: 5 of 57
- Genetics 72
- Hematology 73
- Oncology 109
- Neurology 42
- Clinical Biochemistry 15
Countries citing papers authored by H. Wolf
This map shows the geographic impact of H. Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Wolf more than expected).
Fields of papers citing papers by H. Wolf
This network shows the impact of papers produced by H. Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Wolf. The network helps show where H. Wolf may publish in the future.
Co-authors
The 25 scholars most cited alongside H. Wolf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 76 | |
| 2 | 2020 | 64 | |
| 3 | 2010 | 50 | |
| 4 | 2011 | 37 | |
| 5 | 2021 | 36 | |
| 6 | 2020 | 27 | |
| 7 | 1998 | 19 | |
| 8 | 2006 | 11 | |
| 9 | 2010 | 6 | |
| 10 | 1998 | 3 | |
| 11 | 2007 | 2 | |
| 12 | 1978 | 2 | |
| 13 | 1998 | 1 | |
| 14 | 2000 | 1 | |
| 15 | 2015 | 1 | |
| 16 | 2009 | 0 |
About H. Wolf
H. Wolf is a scholar working on Oncology, Hematology, Infectious Diseases, Surgery and Clinical Biochemistry, having authored 16 papers that have together received 336 indexed citations. Recurring topics across this work include Neutropenia and Cancer Infections (6 papers), COVID-19 Clinical Research Studies (2 papers), COVID-19 and healthcare impacts (2 papers), Blood disorders and treatments (2 papers), Acute Myeloid Leukemia Research (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Hematopoietic Stem Cell Transplantation (1 paper) and Antibiotics Pharmacokinetics and Efficacy (1 paper). The work is most often cited by research in Genetics (72 citations), Hematology (73 citations), Oncology (109 citations), Neurology (42 citations) and Clinical Biochemistry (15 citations). H. Wolf has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Dirk Arnold, Karin Jordan, Hans‐Joachim Schmoll, Wieland Voigt, Axel Hinke, Axel F. Grothey, Marcus Hentrich, Marie von Lilienfeld‐Toal, Dieter Buchheidt and Gero Massenkeil. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, Blood, Supportive Care in Cancer and Acta Neurologica Scandinavica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.